Director/PDMR Shareholding

RNS Number : 0835J
IP Group PLC
31 March 2015
 



 

FOR IMMEDIATE RELEASE

31 MARCH 2015

 

IP Group plc - Director / PDMR Shareholding and Issue of Equity

 

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property-based businesses, announces that it has today issued 1,552,144 new ordinary shares of 2p each (the "Shares") following the vesting of conditional awards of shares made under the Company's Long-Term Incentive Scheme (the "Scheme") in 2012 (the "2012 Awards").

 

As a result, the Company today received notification from the following Directors/Persons Discharging Managerial Responsibilities in relation to the acquisition of Shares under the Scheme and subsequent sale, at an aggregate price of 226 pence per share, as set out in the table below.

 





Resultant beneficial interest

Director/PDMR

Position

Shares vested

Shares sold

Shares

%

Alan Aubrey

Chief Executive Officer

302,695

234,384

2,436,848

0.45%

Mike Townend

Chief Investment Officer

230,625

178,578

1,063,070

0.20%

Greg Smith

Chief Financial Officer

142,768

110,549

322,138

0.06%

Angela Leach

Company Secretary

109,821

109,821

215,823

0.04%

 

In addition, the Company has today received notification from David Baynes, Chief Operating Officer, that he has sold 200,000 shares in the Company at an aggregate price of 226 pence per share. Following the sale, Mr Baynes is beneficially interested in 226,066 shares in the Company representing 0.04%.

 

An application has been made to the Financial Conduct Authority for admission of the Shares to the premium listing segment of the Official List maintained by the UK Listing Authority and to the London Stock Exchange. It is expected that admission will take place on 7 April 2015.

 

Following this issue of shares, the Company has 537,965,429 ordinary shares in issue.

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive Officer
Greg Smith, Chief Financial Officer            

+44 (0) 20 7444 0050
+44 (0) 20 7444 0050

Vicki Bradley, Communications   

+44 (0) 20 7444 0062

FTI Consulting


James Melville-Ross/Simon Conway/
Victoria Foster Mitchell

+44 (0)20 3727 1000

 

 

Notes for editors

 

About IP Group

 

IP Group is a leading UK intellectual property commercialisation company, developing technology innovations primarily from its research intensive partner universities. The Group offers more than traditional venture capital, providing its companies with access to business building expertise, networks, recruitment and business support.

 

IP Group's portfolio comprises holdings in around 90 early-stage to mature businesses across the Healthcare, Biotech, Cleantech and Technology sectors. These businesses include Oxford Nanopore Technologies, the DNA sequencing development company, Revolymer, best known for its removable chewing gum, and Xeros, which has received many accolades for its revolutionary clothes washing techniques with a much reduced requirement for water.

 

For more information, please visit our website at www.ipgroupplc.com.

 

 

ENDS


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSWGURGWUPAGMG

Companies

IP Group (IPO)
UK 100

Latest directors dealings